Methylene blue: Between scylla (meta-analysis) and charybdis (propensity)

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 28, Issue 2, 2014, Pages

  Landoni, Giovanni ^a   Pasin, Laura ^a   Di Prima, Ambra Licia ^a   Dossi, Roberto ^a   Taddeo, Daiana ^a   Zangrillo, Alberto ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLENE BLUE; NORADRENALIN; VASOPRESSIN; HYPERTENSIVE AGENT;

CONFOUNDING VARIABLE; HEART SURGERY; HIGH RISK PATIENT; HUMAN; LETTER; PATIENT IDENTIFICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPENSITY SCORE; SELECTION BIAS; SURGICAL MORTALITY; VASOPLEGIA; ANESTHESIST; DISEASE CONTROL; ELECTRONIC MEDICAL RECORD; MEAN ARTERIAL PRESSURE; META ANALYSIS; MORTALITY; PHYSICIAN; RISK FACTOR; SOCIAL NETWORK; STANDARD; SURGICAL RISK; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT RESPONSE;

BLOOD PRESSURE; CARDIAC SURGICAL PROCEDURES; HUMANS; META-ANALYSIS AS TOPIC; METHYLENE BLUE; PROPENSITY SCORE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL; VASCULAR RESISTANCE; VASOPLEGIA;

EID: 84896357667     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2013.12.012     Document Type: Letter

References (4)

1. L. Pasin, M. Umbrello, and T. Greco et al. Methylene blue as a vasopressor: A meta-analysis of randomised trials Crit Care Resusc 15 2013 42 48
2. M.M. Weiner, H.M. Lin, and D. Danforth et al. Methylene blue is associated with poor outcomes in vasoplegic shock J Cardiothorac Vasc Anesth 27 2013 1233 1238
3. D. Sparicio, G. Landoni, and A. Zangrillo Angiotensin-converting enzyme inhibitors predispose to hypotension refractory to norepinephrine but responsive to methylene blue J Thorac Cardiovasc Surg 127 2004 608
4. D. Sparicio, G. Landoni, and F. Pappalardo et al. Methylene blue for lithium-induced refractory hypotension in off-pump coronary artery bypass graft: report of two cases J Thorac Cardiovasc Surg 127 2004 592 593